Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
A RCT Comparing the Effects of Providing Clinicians and Patients With the Results of an Objective Measure of Activity and Attention (QbTest) Versus Usual Care on Diagnostic and Treatment Decision Making in Children and Young People With ADHD
Attention Deficit/Hyperactivity Disorder (ADHD)is one of the most common mental health
disorders of childhood. Children with ADHD often have poor attention, are restless and
hyperactive and show impulsive behaviour.
It is important to detect ADHD so young people can have access to appropriate clinical
interventions.
One of the most common ways ADHD is assessed is through the clinician's opinionÍž however,
this can vary between clinicians and is thought to be one reason why ADHD may be
mis-diagnosed. Using a more objective computer tasks may help improve our understanding of
ADHD. One computer task is the QbTest.
The test presents different symbols to the child, and the child has to respond by pressing a
button only when a target symbol appears. The test measures the child's attention,
impulsivity and movement whilst doing this task.
Although the test is thought to be a valid measure, more research needs to be conducted on
this measure to see whether it helps clinicians decision making.
To see whether this test helps clinicians make a diagnosis of ADHD and helps with medication
decisions, children and young people will be asked to complete the task as part of their
initial assessment for ADHD. Half the participants and their clinician will have access to
the QbTest resultÍž the other half will not have access to the QbTest result until the end of
the study.
Participant's parents, teachers and the clinician will also be asked to complete some
questionnaires about the child's symptoms and behaviour. If the child is diagnosed with ADHD
and is given medication they will be asked to complete the task again on medication. The
same set of questionnaires will be completed by the parents/teachers/clinicians.
The entire sample will be followed up at 6 months and asked to complete the questionnaires.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
| Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
| Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
| Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
| Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
| Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
| Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
| Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
| Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
| Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
| Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
| Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
| Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
| Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
| Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |